A single dose of Abeona Therapeutics’ investigational gene therapy ABO-102 safely preserved normal cognitive development for up to three…
Marta Figueiredo, PhD
Marta holds a biology degree, a master’s in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbon’s Faculty of Medicine.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marta Figueiredo, PhD
Genetic metabolic diseases, such as Sanfilippo syndrome, may underlie an autism spectrum disorder (ASD) diagnosis, especially when accompanied with additional…
Sanfilippo syndrome’s characteristic buildup — to toxic levels — of the complex sugar molecule heparan…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
A gene therapy delivered through a more effective viral carrier safely and effectively corrected enzymatic deficiency, restored cognitive…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
Parents and relatives of those with Sanfilippo syndrome have a more positive perception of expanded carrier screening (ECS)…
Mucopolysaccharidosis (MPS) type IVA (Morquio A syndrome) is the most common type of MPS in Mexico, followed by…
Researchers have developed an efficient way of screening newborns for eight lysosomal storage diseases — including five mucopolysaccharidosis (MPS) disorders — at…
The U.S. Food and Drug Administration (FDA) has released draft guidelines for the design of clinical trials evaluating investigational therapies…